EUVIMEDEUVIMED entdecken
Crossref

Exploring PU .1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis‐Induced Peritoneal Fibrosis

Shuo Zhong, Wenyan Su, Yunzhao Wang, Dan Liu, Xiumei Li, Fangzhou Ma, Liang Xu, Jie Gao iD, Haiping Wang iD, Jing Sun

The FASEB Journal · 2025

DOI: 10.1096/fj.202500305rr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Shuo Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Peritoneal Fibrosis, Peritoneal Dialysis, Oxidative Stress, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: National Science Fundation for Young Scholars of China, Science and Technology Development Plan Program of Medicine and Health of Shandong Province, Jinan Science and Technology Development Plan Clinical Medicine Technology Innovation Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transcription factor PU.1 has been implicated in various fibrotic diseases; however, its role in peritoneal dialysis‐associated peritoneal fibrosis (PF) remains unclear. The role of PU.1 was investigated using knockdown approaches with AAV9‐shPU.1 in a rat PF model and siRNA in human peritoneal mesothelial cells (MeT‐5A). Multiple experimental techniques, including real‐time quantitative PCR, western blot, enzyme‐linked immunosorbent assay (ELISA), and immunohistochemical staining, were utilized. In vivo, PU.1 expression was significantly upregulated in the rat PF model. Knockdown of PU.1 ameliorated peritoneal thickening, collagen deposition, angiogenesis, inflammation, and oxidative stress. In vitro, high‐glucose exposure upregulated PU.1 expression in MeT‐5A cells, promoting fibrosis and angiogenesis. PU.1 knockdown reduced fibrosis‐related markers and suppressed the IL‐6/JAK1/STAT3 signaling pathway, a critical regulator of PF. Treatment with an IL‐6 inhibitor further confirmed that PU.1 modulates fibrosis through this pathway. PU.1 plays a pivotal role in the progression of PF. Its knockdown mitigates fibrosis by reducing inflammation and angiogenesis, and suppressing the activation of the IL‐6/JAK1/STAT3 pathway, highlighting its potential as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal FibrosisPeritoneal DialysisOxidative StressInflammationProto-Oncogene ProteinsTrans-ActivatorsAnimalsRatsHumansMaleRats, Sprague-DawleySTAT3 Transcription FactorSignal TransductionInterleukin-6PeritoneumProto-Oncogene Protein Spi-1

Stichwörter der Autor:innen

IL‐6JAK1PU.1STAT3angiogenesisoxidative stressperitoneal fibrosis

Substanzen

Proto-Oncogene ProteinsTrans-ActivatorsSTAT3 Transcription FactorInterleukin-6Proto-Oncogene Protein Spi-1

Autor:innen und Institutionen

  • Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
  • Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
  • Department of Nephrology, Yanzhou District People's Hospital, Jining, Shandong, China.
  • Department of Nephrology, The People's Hospital of Zouping City, Binzhou, Shandong, China.
  • Department of Nephrology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

ORCID-Profile: Jie Gao, Haiping Wang

Förderung

  • National Science Fundation for Young Scholars of China
  • Science and Technology Development Plan Program of Medicine and Health of Shandong Province
  • Jinan Science and Technology Development Plan Clinical Medicine Technology Innovation Plan
  • Shandong Provincial Natural Science Foundation General Project
  • Young Scientist Fund Training Program of Shandong First Medical University (Shandong Academy of Medical Sciences)
  • Shandong Academy of Medical Sciences

Zitieren

APA

Zhong, S., Su, W., Wang, Y., Liu, D., Li, X., Ma, F., Xu, L., Gao, J., Wang, H., & Sun, J. (2025). Exploring PU .1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis‐Induced Peritoneal Fibrosis. The FASEB Journal. https://doi.org/10.1096/fj.202500305rr

Vancouver

Zhong S, Su W, Wang Y, Liu D, Li X, Ma F, et al. Exploring PU .1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis‐Induced Peritoneal Fibrosis. The FASEB Journal. 2025. doi:10.1096/fj.202500305rr

BibTeX
@article{Zhong2025,
  author = {Zhong, Shuo and Su, Wenyan and Wang, Yunzhao and Liu, Dan and Li, Xiumei and Ma, Fangzhou and Xu, Liang and Gao, Jie and Wang, Haiping and Sun, Jing},
  title = {Exploring PU .1 as a Therapeutic Target to Mitigate Oxidative Stress and Inflammation in Peritoneal Dialysis‐Induced Peritoneal Fibrosis},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202500305rr}
}
Kostenlos starten →